News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,748 Results
Type
Article (15764)
Company Profile (262)
Press Release (280713)
Multimedia
Podcasts (127)
Webinars (13)
Section
Business (90833)
Career Advice (170)
Deals (13529)
Drug Delivery (69)
Drug Development (51105)
Employer Resources (34)
FDA (6011)
Job Trends (5225)
News (145945)
Policy (10093)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (19)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (978)
Accelerated approval (39)
ADA (34)
Adcomms (16)
Allergies (128)
Alliances (21772)
ALS (204)
Alzheimer's disease (1263)
Antibody-drug conjugate (ADC) (582)
Approvals (6442)
Artificial intelligence (491)
ASCO (224)
Autoimmune disease (410)
Automation (20)
Bankruptcy (112)
Belgium (30)
Best Places to Work (4559)
BIO (56)
Biologics (71)
BIOSECURE Act (6)
Biosimilars (161)
BioSpace Insights (81)
Biotechnology (179)
Bispecific (54)
Bladder cancer (143)
Brain cancer (73)
Breast cancer (510)
Cancer (5048)
Cardiovascular disease (375)
Career advice (174)
Career pathing (15)
CAR-T (347)
CDC (11)
CDMO (127)
Celiac Disease (6)
Cell therapy (888)
Cervical cancer (31)
Clinical research (46645)
Collaboration (1779)
Commercialization (44)
Company closure (4)
Compensation (988)
Complete response letters (73)
COVID-19 (1156)
CRISPR (131)
CRO (4)
C-suite (1057)
Cystic fibrosis (132)
Data (7642)
Denatured (27)
Depression (134)
Dermatology (131)
Diabetes (404)
Diagnostics (1562)
Digital health (21)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (360)
Drug pricing (55)
Drug shortages (4)
Duchenne muscular dystrophy (343)
Earnings (33924)
Editorial (38)
Employer branding (4)
Employer resources (32)
ESMO (311)
Events (55588)
Executive appointments (804)
Eye disease (16)
FDA (8827)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (36)
Funding (1495)
Gene editing (264)
Generative AI (50)
Gene therapy (725)
GLP-1 (638)
Government (1217)
Grass and pollen (3)
Guidances (182)
Healthcare (6833)
Hematology (144)
HIV (40)
Huntington's disease (75)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (125)
Immunology and inflammation (291)
Immuno-oncology (123)
Indications (191)
Infectious disease (1338)
Inflammatory bowel disease (216)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (262)
Interviews (21)
IPO (7423)
IRA (13)
Job creations (871)
Job search strategy (139)
JPM (41)
Kidney cancer (13)
Kidney disease (126)
Labor market (47)
Layoffs (280)
Leadership (22)
Legal (1406)
Licensing (99)
Liver cancer (54)
Longevity (39)
Lung cancer (701)
Lung diease (21)
Lymphoma (369)
Machine learning (37)
Management (10)
Manufacturing (713)
Marketing (25)
MASH (189)
Medical affairs (4)
Medical device (2759)
Medtech (2814)
Melanoma (110)
Mergers & acquisitions (6993)
Metabolic disorders (1117)
Middle East (1)
mRNA (230)
Multiple sclerosis (162)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (433)
Neuropsychiatric disorders (105)
Neuroscience (2778)
Neurotech (2)
NextGen: Class of 2026 (2041)
Non-profit (892)
Now hiring (50)
Obesity (496)
Opinion (162)
Ovarian cancer (232)
Pain (175)
Pancreatic cancer (312)
Parkinson's disease (366)
Partnered (19)
Patents (512)
Patient advocacy (7)
Patient recruitment (682)
Patient selection (93)
Peanut (55)
People (27977)
Peptides (33)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16517)
Phase 2 (21706)
Phase 3 (13732)
Pipeline (9241)
Policy (115)
Postmarket research (853)
Preclinical (6978)
Press Release (30)
Prostate cancer (247)
Psychedelics (89)
Radioligand (3)
Radiopharmaceuticals (342)
Rare diseases (1133)
Real estate (1461)
Recruiting (13)
Regenerative medicine (24)
Regulatory (11462)
Reports (33)
Research institute (1008)
Resumes & cover letters (20)
Rett syndrome (51)
RNA editing (38)
RSV (26)
Schizophrenia (175)
Series A (295)
Series B (198)
Series C (1)
Service/supplier (1)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (131)
Sponsored (22)
Startups (2058)
State (1)
Stem cells (7)
Stomach cancer (7)
Substance use disorders (20)
Supply chain (49)
Switzerland (15)
Tariffs (20)
The Weekly (98)
Vaccines (472)
Venture capital (120)
Weight loss (263)
Wet AMD (6)
Women's health (63)
Women in leadership (1)
Worklife (4)
Date
Today (14)
Last 7 days (395)
Last 30 days (2179)
Last 365 days (18399)
2026 (16918)
2025 (18096)
2024 (20468)
2023 (22413)
2022 (26811)
2021 (27802)
2020 (23356)
2019 (16224)
2018 (11736)
2017 (13744)
2016 (11840)
2015 (14350)
2014 (10395)
2013 (7485)
2012 (7532)
2011 (7615)
2010 (7430)
Location
Africa (160)
Alabama (86)
Alaska (2)
Arizona (108)
Arkansas (6)
Asia (19316)
Australia (3328)
California (10483)
Canada (2597)
China (1383)
Colorado (397)
Connecticut (395)
Delaware (364)
Europe (41381)
Florida (1380)
Georgia (289)
Hawaii (3)
Idaho (18)
Illinois (656)
India (78)
Indiana (246)
Iowa (13)
Japan (408)
Kansas (93)
Kentucky (13)
Louisiana (18)
Maine (14)
Maryland (1072)
Massachusetts (8370)
Michigan (143)
Minnesota (362)
Mississippi (4)
Missouri (41)
Montana (17)
Nebraska (6)
Nevada (71)
New Hampshire (22)
New Jersey (2357)
New Mexico (14)
New York (2545)
North Carolina (1214)
North Dakota (9)
Northern California (5449)
Ohio (254)
Oklahoma (12)
Oregon (28)
Pennsylvania (1899)
Puerto Rico (12)
Rhode Island (31)
South America (217)
South Carolina (20)
Southern California (4257)
Tennessee (72)
Texas (1505)
United States (34544)
Utah (145)
Virginia (212)
Washington D.C. (37)
Washington State (850)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
296,748 Results for "pendulum therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pendulum Therapeutics Appoints Madison Reed Founder and CEO Amy Errett to Board of Directors
June 25, 2026
·
4 min read
Press Releases
Pendulum Therapeutics Expands Clinical Collaboration to Advance Microbiome Research in Women’s Health and Dermatology
April 12, 2026
·
2 min read
Press Releases
Pendulum Therapeutics Appoints Former Starbucks CEO Laxman Narasimhan to Board of Directors
October 7, 2025
·
4 min read
Business
Dr. Adam Perlman, Former Medical Director at Mayo Clinic, Joins Pendulum Therapeutics as Chief Medical Officer
Today, Pendulum Therapeutics , the leading microbiome biotech company pioneering the next frontier of metabolic health, announced that former Mayo Clinic Medical Director and Executive Director for Integrative Medicine at Duke University, Adam Perlman, MD, MPH, FACP, has joined the company as Chief Medical Officer.
January 9, 2024
·
5 min read
Drug Development
Opinion: AI Is Pushing the I&I Pendulum From Biologics to Small Molecules
Drug development powered by artificial intelligence is countering incentives from the Inflation Reduction Act and making small molecules more attractive in the complex inflammatory & immunology disease space.
February 24, 2025
·
6 min read
·
Christian Antoni
Funding
Marrow Therapeutics debuts with $173M to tackle blood disorders in vivo
Marrow Therapeutics aims to address safety and accessibility obstacles in genetic medicines by delivering therapies straight to bone marrow cells.
November 17, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Akebia Therapeutic’s Vafseo® (vadadustat) Granted Additional Patent
November 17, 2026
·
10 min read
Biotech Bay
Halle Berry, Long-Standing Pendulum Customer, Joins Company as Chief Communications Officer, and Becomes Equity Owner and Investor
Pendulum Therapeutics announced that Halle Berry, Academy Award® winning actress and director, has joined the company as equity owner, investor and Chief Communications Officer.
February 9, 2023
·
4 min read
Biotech Bay
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila, a Key Strain Forging a Path for the Future of Probiotics
Pendulum Therapeutics Releases In-Depth Profile of Akkermansia muciniphila , a Key Strain Forging a Path for the Future of Probiotics.
June 10, 2022
·
2 min read
Biotech Bay
Pendulum Therapeutics Provides Leadership in Microbiome Education among Healthcare Professionals
Pendulum Therapeutics, a trailblazer in microbiome science and a pioneer in DNA sequencing, is leading healthcare professional education on the microbiome and its relationship to metabolic disease, including type 2 diabetes.
October 28, 2021
·
3 min read
1 of 29,675
Next